Does Neulasta cause bone pain?
Yes, Neulasta can cause the side effect of bone pain. Bone pain is considered to be a very common side effect of Neulasta:
- bone pain (up to 31%)
- skeletal pain (up to 27%)
- medullary bone pain (up to 26%)
Why does Neulasta cause bone pain?
Neulasta (pegfilgrastim) can be used to increase the neutrophil levels by stimulating production, maturation, activation and release of neutrophils from the bone marrow.
Because Neulasta has its clinical effect within the bone marrow, it is these changes that also causes the side effects of bone pain, skeletal pain and medullary bone pain.
Neulasta is thought to cause bone pain by affecting:
- bone marrow expansion
- bone metabolism
- peripheral nerve being sensitized
- histamine which can cause inflammation and local swelling
Patients undergoing chemotherapy often have a decrease in neutrophils (a type of white blood cell that fights infection) which makes them susceptible to infections. These patients can take Neulasta to help increase neutrophil levels, to help reduce infection risk.
How long does bone pain last from Neulasta?
Reliable information on how long bone pain from Neulasta lasts is not easily available.
In the NOLAN study of bone pain caused by Neulasta
- pain usually starts within two days of administration
- the most painful day was day 3
- then pain improved slightly on day 4 and day 5.
This study only measured pain up to day 5, when there was still a high level of pain and pain had not yet returned to pre-treatment levels.
In another study patients' pain levels were measured before Neulasta treatment, then 8 days after treatment and the results showed
- 49% (111 of 227 patients) still had pain 8 days after treatment that was at a higher level than before treatment.
These studies indicate that bone pain from Neulasta lasts at least 8 days for almost half of the patients, and bone pain is likely to last a lot longer for a number of patients.
Related questions
- What are biosimilar drugs and how do they compare to biologics?
- How do you increase white blood cells during chemo?
- What is the difference between Fulphila and Neulasta?
Bottom line:
- Bone pain is a very common side effect of Neulasta
- Neulasta has a positive effect on bone causing increases in neutrophil levels, but also Neulasta has a negative effect which causes bone pain due to bone marrow expansion, bone metabolism, peripheral nerve being sensitized and affecting histamine which can cause inflammation and local swelling.
- Bone pain caused by Neulasta lasts at least 8 days for 49% of the patients, and most likely longer for a large number of patients.
References
- Neulasta side effect information: https://www.drugs.com/sfx/neulasta-side-effects.html
- Neulasta medicine information: https://www.drugs.com/pro/neulasta.html
- NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847062/
- Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266505/
Read next
What is the difference between Udenyca and Neulasta?
Udenyca (pegfilgrastim-cbqv) and Neulasta (pegfilgrastim) are both biological drugs containing pegfligrastim.
The US Food and Drug Administration (FDA) has approved Udencya as a biosimilar of Neulasta, which means it is "highly similar to, and has no clinically meaningful differences from" Neulasta - it is just as safe and effective and used in the same way. The two drugs, however, are not interchangeable. Continue reading
What does cbqv stand for in pegfilgrastim?
The “cbqv” suffix is found in the biosimilar name for Udenyca (pegfilgrastim-cbqv), a biologic drug used to prevent neutropenia (a lack of certain white blood cells) caused by receiving chemotherapy. The suffix is used to distinguish its name from the original reference product, in this case Neulasta (pegfilgrastim), which has no suffix. The suffix on biosimilars helps healthcare providers and patients realize the medicine is an approved biosimilar, but the suffix has no specific meaning itself. Continue reading
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Vyepti
Vyepti (eptinezumab-jjmr) is used for the preventive treatment of migraine. Includes Vyepti ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Inderal
Inderal (propranolol) is used to treat angina, high blood pressure and heart rhythm disorders ...
Ajovy
Ajovy (fremanezumab-vfrm) is a preventive migraine treatment. Includes Ajovy side effects ...
Valproate Sodium
Valproate Sodium is used for epilepsy, seizure prevention, seizures
Related medical questions
- Why do you take Claritin with Neulasta?
- What biosimilars have been approved in the United States?
- How long do the side effects of the Neulasta (pegfilgrastim) shot last?
- When does Neulasta reach peak levels?
- When can I remove the Neulasta Onpro?
- Can you shower with Neulasta on body injector?
Drug information
Related support groups
- Neulasta (18 questions, 27 members)
- Pegfilgrastim (13 questions, 4 members)
- Pain (2,281 questions, 11,946 members)
- Neutropenia Associated with Chemotherapy (12 questions, 5 members)
- Neutropenia Associated with Radiation (5 questions, 3 members)